Funded Tech Companies
Zetagen Therapeutics
Based in Syracuse, Zetagen Therapeutics has funding from Consolidated Investment Group and New York Ventures.
Company Overview
Company Name
Zetagen Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
841 East Fayette Street 1100
Syracuse, NY 13210
USA
Syracuse, NY 13210
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic interventions. Our multi-patented, ZetaMet� technology is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone. Zetagen exclusively-licensed the platform technology from the State University of New York in 2016.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/11/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joe Loy
Chief Financial Officer
Jess Pletka
Chief Scientific Officer
Bryan Margulies
Company Investors
- Consolidated Investment Group
- New York Ventures
Browse more funded tech companies:
ZetaChain | ZetaRx Biosciences
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs